Type 2 & other diabetes

Gaps in glucagon fills among commercially insured patients receiving a glucagon prescription

Diabetes Res Clin PractPublished Retrospective cohort study

Study context

Population
Commercially insured, high-risk individuals with diabetes prescribed glucagon in the authors' healthcare system
Participants
216 participants
Outcome
Claim indicating glucagon fill
Follow-up
Within 30 days

Main finding

As reported in the abstract

Glucagon prescription filled (claim)

Claim indicating glucagon fill within 30 days

142

65.4%

Observational data: associations, not effects.

Original publication

Gaps in glucagon fills among commercially insured patients receiving a glucagon prescription. Diabetes Res Clin Pract. Published 16 May 2023. doi:10.1016/j.diabres.2023.110720

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.